Sharenet Sites 
Sharenet Sites
Dealing in Securities by Directors, Prescribed Officers and the Company Secretary
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Group")
DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, shareholders are
advised of the dealings in securities as set out below.
Deferred bonus shares, awarded in 2021 in respect of the Aspen South African Management Deferred
Incentive Bonus Scheme have vested and have been delivered to the undermentioned directors,
prescribed officers and company secretary.
DIRECTORS
Director : Stephen Bradley Saad
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 22 098
Price on vesting : R195.30
Value of vesting : R4 315 739.40
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Director : Sean Matthew Capazorio
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale of shares
Number of securities vested : 10 450
Price on vesting : R195.30
Value of vesting : R2 040 885.00
Number of shares sold : 10 450
Sale price (weighted average) : R195.53
Highest sale price : R196.66
Lowest sale price : R195.00
Value of sale : R2 043 252.97
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Reginald Thomas Haman
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale of shares
Number of securities vested : 8 604
Price on vesting : R195.30
Value of vesting : R1 680 361.20
Number of shares sold : 8 604
Sale price (weighted average) : R195.53
Highest sale price : R196.66
Lowest sale price : R195.00
Value of sale : R1 682 310.87
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
PRESCRIBED OFFICERS
Name : Michael Guy Attridge
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 18 268
Price on vesting : R195.30
Value of vesting : R3 567 740.40
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Name : Lorraine Angela Hill
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale to settle the tax liability
Number of securities vested : 15 008
Price on vesting : R195.30
Value of vesting : R2 931 062.40
Number of shares sold : 6 978
Sale price (weighted average) : R195.53
Highest sale price : R196.66
Lowest sale price : R195.00
Value of sale : R1 364 384.61
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Name : Zizipho Mmango
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale to settle the tax liability
Number of securities vested : 9 254
Price on vesting : R195.30
Value of vesting : R1 807 306.20
Number of shares sold : 4 303
Sale price (weighted average) : R195.53
Highest sale price : R196.66
Lowest sale price : R195.00
Value of sale : R841 350.96
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
COMPANY SECRETARY
Name : Raeesa Khan
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 2 October 2024
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale of shares
Number of securities vested : 584
Price on vesting : R195.30
Value of vesting : R114 055.20
Number of shares sold : 584
Sale price (weighted average) : R195.53
Highest sale price : R196.66
Lowest sale price : R195.00
Value of sale : R114 187.53
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Durban
07 October 2024
Sponsor
Investec Bank Limited
Date: 07-10-2024 04:02:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
